The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A three-dimensional human neural cell culture model of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beading or blebbing in neurites is a marker of dystrophic neurites in the AD brain (3, 42, 43).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD, tau protein becomes hyperphosphorylated, resulting in tau dissociating from microtubules and forming insoluble tau aggregates in the neurites and cell bodies (3, 37).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Choi et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Modeling these pathological hallmarks has largely relied on transgenic cellular and animal models harboring genetic mutations linked to ADAD (3–5).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“As for human neurons, previous studies focused on overexpressing mutant APP and Presenilin in REN stem cells grown in a 3D culture (3), which differs from patient-specific LOAD model that relies on the endogenous recapitulation of AD-associated phenotypes as provided in this study.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
In the citing paper
“one study revealed that familial AD (FAD) mutations in β-amyloid precursor protein and presenilin 1 induced robust extracellular deposition of amyloid-β in a human neural stem-cell-derived 3D culture system85.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“the 3D-differentiated neuronal cells expressing FAD mutations exhibited aggregates of phosphorylated tau as well as filamentous tau.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“A 3D in vitro culture system consisting of human neurons differentiated from induced pluripotent stem cells overexpressing human APP containing FAD mutations generates robust Aβ42 production and amyloid deposition. Importantly, this model also develops elevated phospho-tau levels and fibrillary tau aggregates, suggesting that elevated Aβ levels alone are sufficient to drive tau pathology in human”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Choi et al., 2014
In the citing paper
“It was recently shown that development of a 3D culture of human neural stem cells transfected with APPK670N/M671L/V717I and PS1ΔE9 in Matrigel scaffolding resulted in the extracellular aggregation of Aβ into plaques and the intracellular aggregation of tau in dystrophic neurites and the cell soma [23, 77].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Cohen, R. M., Rezai-Zadeh, K. P., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I. E., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 555
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379
Flagged first, then by citations
Research works printed but not linked: 1
- Higuchi, M., Trojanowski, J. Q. & Lee, V. M.-Y. Tau protein and tauopathy. Neuropsychopharmacology: The Fifth Generation of Progress (eds Davis, K. L., Charney, D., Coyle, J. T. & Nemeroff, C. ) 1339–1354 (Lippincott, Williams & Wilkins, 2002)
Cited by
Sorted by citations
Items 401–500 of 998
Artificial intelligence for neurodegenerative experimental models
Marzi, S. J., Schilder, B. M., Nott, A., Frigerio, C. S., Willaime‐Morawek, S., Bucholc, M., Hanger, D. P., James, C. R., Lewis, P. A., Lourida, I., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13479 · Cited by 35
Brain organoids: building higher-order complexity and neural circuitry models
Maisumu, G., Willerth, S. M., Nestor, M. W., Waldau, B., Schülke, S., Nardi, F. V., Ahmed, O., Zhou, Y., Durens, M., Liang, B., et al. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.02.009 · Cited by 40
Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
Tang, S., Xie, M., Cao, N., & Ding, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00789 · Cited by 37
Korhonen, P., Malm, T., & White, A. R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.012 · Cited by 34
If Human Brain Organoids Are the Answer to Understanding Dementia, What Are the Questions?
Ooi, L., Dottori, M., Cook, A. L., Engel, M., Gautam, V., Grubman, A., Hernández, D., King, A. E., Maksour, S., Anastacio, H. T. D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420912404 · Cited by 35
Brain organoids: Human 3D models to investigate neuronal circuits assembly, function and dysfunction
Tambalo, M., & Lodato, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147028 · Cited by 36
García‐León, J. A., Cáceres-Palomo, L., Sánchez‐Mejías, E., Mejias‐Ortega, M., Nuñez‐Diaz, C., Fernandez-Valenzuela, J. J., Sanchez-Varo, R. M., Dávila, J. C., Vitórica, J., & Gutiérrez, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186867 · Cited by 35
Torrens‐Mas, M., Perelló-Reus, C. M., Navas-Enamorado, C., Ibargüen-González, L., Sánchez-Polo, A., Segura‐Sampedro, J. J., Masmiquel, L., Barceló, C., & González‐Freire, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910547 · Cited by 38
Infection and inflammation: New perspectives on Alzheimer's disease
Whitson, H. E., Colton, C. A., Khoury, J. B. E., Gate, D., Goate, A., Heneka, M. T., Kaddurah‐Daouk, R., Klein, R. S., Shinohara, M. L., Sisodia, S. S., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100462 · Cited by 34
Self-citationChoe, M. S., Yeo, H. C., Kim, J., Lee, J., Lee, H. J., Kim, H., Baek, K. M., Jung, N., Choi, M., & Lee, M. Y. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03732-1 · Cited by 39
Tang, Y., Liu, L., Li, J., Yu, L., Severino, F. P. U., Wang, L., Shi, J., Tu, X., Torre, V., & Chen, Y. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00351f · Cited by 34
Human induced pluripotent stem cells as a research tool in Alzheimer's disease
Robbins, J. P., & Price, J. (2017) · Psychological Medicine · doi:10.1017/s0033291717002124 · Cited by 34
Ghaffari, L., Starr, A., Nelson, A. T., & Sattler, R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00056 · Cited by 35
Hydrogel-incorporating unit in a well: 3D cell culture for high-throughput analysis
Yu, Y. J., Kim, Y. H., Na, K., Min, S. Y., Hwang, O. K., Park, D. K., Kim, D. Y., Choi, S. H., Kamm, R. D., Chung, S. H., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00525g · Cited by 34
Self-citationPaudel, P., Seong, S. H., Zhou, Y., Park, C. H., Yokozawa, T., Jung, H., & Choi, J. S. (2018) · Molecules · doi:10.3390/molecules23112919 · Cited by 34
Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
Fülöp, T., Munawara, U., Larbi, A., Desroches, M., Rodrigues, S., Catanzaro, M., Guidolin, A., Khalil, A., Bernier, F., Barron, A. E., et al. (2020) · CNS Drugs · doi:10.1007/s40263-020-00737-1 · Cited by 32
A microfiber scaffold-based 3D in vitro human neuronal culture model of Alzheimer's disease
Ranjan, V., Qiu, L., Lee, J. W. L., Chen, X., Jang, S. E., Chai, C., Lim, K., Tan, E., Zhang, Y., Huang, W., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm00833h · Cited by 33
Tunesi, M., Izzo, L., Raimondi, I., Albani, D., & Giordano, C. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420945633 · Cited by 34
Efficient synthesis of longer Aβ peptides via removable backbone modification
Zuo, C., Tang, S., Si, Y., Wang, Z. A., Tian, C., & Zheng, J. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00712k · Cited by 33
Lehnert, S., Hartmann, S., Hessler, S., Adelsberger, H., Huth, T., & Alzheimer, C. (2016) · Channels · doi:10.1080/19336950.2016.1196307 · Cited by 33
Raven, F., Ward, J. F., Zoltowska, K. M., Wan, Y., Bylykbashi, E., Miller, S., Shen, X., Choi, S. H., Rynearson, K. D., Berezovska, O., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.08.028 · Cited by 35
Self-citationModelling Alzheimer's disease: Insights fromin vivotoin vitrothree-dimensional culture platforms
Ranjan, V., Qiu, L., Tan, E., Zeng, L., & Zhang, Y. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2728 · Cited by 41
Gao, F., Gao, K., He, C., Liu, M., Wan, H., & Wang, P. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.03.025 · Cited by 35
Multiscale brain research on a microfluidic chip
Zhao, Y., Demirci, U., Chen, Y., & Chen, P. (2020) · Lab on a Chip · doi:10.1039/c9lc01010f · Cited by 33
Jacob, F., Schnoll, J. G., Song, H., & Ming, G. (2021) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2020.12.011 · Cited by 34
Mitigating Effect of Estrogen in Alzheimer’s Disease-Mimicking Cerebral Organoid
Kim, J. Y., Mo, H., Kim, J., Kim, J. W., Nam, Y., Rim, Y. A., & Ju, J. H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.816174 · Cited by 33
Zhao, Y., Zhong, R. M., Sun, L., Jia, J., Ma, S., & Liu, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121289 · Cited by 33
Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
de Leeuw, S., & Tackenberg, C. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0161-0 · Cited by 31
Advances in 3D neuronal cell culture
Frimat, J., Xie, S., Bastiaens, A. J., Schurink, B., Wolbers, F., den Toonder, J. M. J., & Lüttge, R. (2015) · Journal of Vacuum Science & Technology B Nanotechnology and Microelectronics Materials Processing Measurement and Phenomena · doi:10.1116/1.4931636 · Cited by 32
iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia
Li, L., Roh, J. H., Chang, E. H., Lee, Y. K., Lee, S., Kim, M., Koh, W., Chang, J. W., Kim, H. J., Nakanishi, M., et al. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.350 · Cited by 32
Self-citationAutomated Live-Cell Imaging of Synapses in Rat and Human Neuronal Cultures
Green, M. V., Pengo, T., Raybuck, J. D., Naqvi, T., McMullan, H. M., Hawkinson, J. E., de Velasco, E. M. F., Muntean, B. S., Martemyanov, K. A., Satterfield, R., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00467 · Cited by 32
Wan, Y., Liang, Y., Liang, F., Shen, N., Shinozuka, K., Yu, J., Ran, C., Quan, Q., Tanzi, R. E., & Zhang, C. M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190562 · Cited by 31
Self-citationMolecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates
Xu, Y., Wang, C., Wey, H., Liang, Y., Chen, Z., Choi, S. H., Ran, C., Rynearson, K. D., Bernales, D. R., Koegel, R. E., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20182266 · Cited by 31
Self-citationResolving Neurodevelopmental and Vision Disorders Using Organoid Single-Cell Multi-omics
Brancati, G., Treutlein, B., & Camp, J. G. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.001 · Cited by 32
Heterotypic interactions in amyloid function and disease
Konstantoulea, K., Louros, N. N., Rousseau, F., & Schymkowitz, J. W. H. (2021) · FEBS Journal · doi:10.1111/febs.15719 · Cited by 34
Lim, E. T., Chan, Y., Dawes, P., Guo, X., Erdin, S., Tai, D. J. C., Liu, S., Reichert, J. M., Burns, M. J., Chan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30968-3 · Cited by 34
Lantero‐Rodriguez, J., Tissot, C., Snellman, A., Servaes, S., Benedet, A. L., Rahmouni, N., Montoliu‐Gaya, L., Therriault, J., Brum, W. S., Stevenson, J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13119 · Cited by 30
A new perspective on Alzheimer’s disease: m6A modification
Xia, L., Zhang, F., Li, Y., Mo, Y., Zhang, L., Li, Q., Luo, M., Hou, X., Du, Z., Deng, J., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1166831 · Cited by 32
Zhang, L., Sun, C., Jin, Y., Gao, K., Shi, X., Qiu, W., Ma, C., & Zhang, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161254 · Cited by 30
Stem cell models of human synapse development and degeneration
Wilson, E. S., & Litwa, K. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-04-0222 · Cited by 30
Induction of Neuroinflammation and Neurotoxicity by Synthetic Hemozoin
Velagapudi, R., Kosoko, A. M., & Olajide, O. A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00713-4 · Cited by 32
Xiang, J., Cao, K., Dong, Y., Xu, Y., Li, Y., Song, H., Zeng, X., Ran, L., Hong, W., & Guan, Z. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1688808 · Cited by 31
Wang, J., Hu, L., Huang, H., Yu, Y., Wang, J., Yu, Y., Li, K., Li, Y., Tian, T., & Chen, F. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15554 · Cited by 31
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31
Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer’s disease in an induced neuron
Kim, H., Yoo, J., Shin, J., Chang, Y., Jung, J., Jo, D., Kim, J., Jang, W., Lengner, C. J., Kim, B., et al. (2017) · Brain · doi:10.1093/brain/awx144 · Cited by 30
Simpson, L. W., Szeto, G. L., Boukari, H., Good, T. A., & Leach, J. B. (2020) · ACS Omega · doi:10.1021/acsomega.0c02046 · Cited by 32
de Sá, R. V., Luna, M. C., & Pasterkamp, R. J. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2020.0337 · Cited by 31
Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33
Pinnock, E. C., Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. D. C., Penny, C. B., Knackmuss, S. H. J., Reusch, U., Little, M., Schätzl, H. M., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150482 · Cited by 29
Barucker, C., Bittner, H. J., Chang, P. K. ‐., Cameron, S., Hancock, M. A., Liebsch, F., Hossain, S., Harmeier, A., Shaw, H. S., Charron, F. M., et al. (2015) · Scientific Reports · doi:10.1038/srep15410 · Cited by 32
Bejoy, J., Song, L., Wang, Z., Sang, Q. A., Zhou, Y., & Li, Y. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00021 · Cited by 31
Sproul, A. A. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.007 · Cited by 31
Trevisan, M., Sinigaglia, A., Desole, G., Berto, A., Pacenti, M., Palù, G., & Barzon, L. (2015) · Viruses · doi:10.3390/v7072800 · Cited by 28
Gu, H., Li, L., Cui, C., Zhao, Z., & Song, G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4977 · Cited by 28
AβPeptide Originated from Platelets Promises New Strategy in Anti-Alzheimer’s Drug Development
Inyushin, M. Y., Sanabria, P., Rojas, L. V., Kucheryavykh, Y. V., & Kucheryavykh, L. Y. (2017) · BioMed Research International · doi:10.1155/2017/3948360 · Cited by 30
Nierode, G. J., Gopal, S., Kwon, P. S., Clark, D. S., Schaffer, D. V., & Dordick, J. S. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26839 · Cited by 30
García‐León, J. A., Vitórica, J., & Gutiérrez, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0520 · Cited by 30
Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
Trudler, D., Ghatak, S., & Lipton, S. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158196 · Cited by 30
Chrysanthou, M., Estruch, I. M., Rietjens, I. M. C. M., Wichers, H. J., & Hoppenbrouwers, T. (2022) · Nutrients · doi:10.3390/nu14020363 · Cited by 31
Alzheimer's disease amyloid-β pathology in the lens of the eye
Moncaster, J. A., Moir, R. D., Burton, M. A., Chadwick, O., Minaeva, O. V., Alvarez, V. E., Ericsson, M., Clark, J. I., McKee, A. C., Tanzi, R. E., et al. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.108974 · Cited by 30
Self-citationVargas, J. A. G., Castro-Álvarez, J. F., Berruecos, J. F. Z., Abdul‐Rahim, K., & Arteaga‐Noriega, A. (2022) · Biomedical Reports · doi:10.3892/br.2022.1510 · Cited by 31
Substitution of PINK1 Gly411 modulates substrate receptivity and turnover
Fiesel, F. C., Fričová, D., Hayes, C. S., Coban, M. A., Hudec, R., Bredenberg, J. M., Broadway, B. J., Markham, B. N., Yan, T., Boneski, P. K., et al. (2023) · Autophagy · doi:10.1080/15548627.2022.2151294 · Cited by 29
Hebisch, M., Klostermeier, S., Wolf, K., Boccaccini, A. R., Wolf, S. E., Tanzi, R. E., & Kim, D. Y. (2023) · Advanced Science · doi:10.1002/advs.202205037 · Cited by 31
Self-citationModelling frontotemporal dementia using patient-derived induced pluripotent stem cells
Lines, G., Casey, J. M., Preza, E., & Wray, S. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103553 · Cited by 30
Ko, E. C., Spitz, S., Pramotton, F. M., Barr, O. M., Xu, C., Pavlou, G., Zhang, S., Tsai, A., Maaser‐Hecker, A., Jorfi, M., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1251195 · Cited by 27
Self-citationRole of cellular prion protein in interneuronal amyloid transmission
del Rı́o, J. A., Ferrer, I., & Gavı́n, R. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.03.001 · Cited by 30
Neuro-regeneration Therapeutic for Alzheimer’s Dementia: Perspectives on Neurotrophic Activity
Sun, M., & Alkon, D. L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.07.008 · Cited by 31
Liang, Y., Raven, F., Ward, J. F., Zhen, S. Y., Zhang, S., Sun, H., Miller, S., Choi, S. H., Tanzi, R. E., & Zhang, C. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200128 · Cited by 29
Self-citationWang, H., Yang, H. M., Shi, Y., Xiao, Y., Yin, Y., Jiang, B.-X., Ren, H., Chen, W., Xue, Q., & Xu, X. (2021) · Brain Pathology · doi:10.1111/bpa.12940 · Cited by 27
Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches
Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., García‐León, J. A., Nuñez‐Diaz, C., Dávila, J. C., Vitórica, J., LaFerla, F. M., Moreno‐González, I., Gutiérrez, A., et al. (2021) · The Neuroscientist · doi:10.1177/10738584211001753 · Cited by 30
Engineering in vitro human neural tissue analogs by 3D bioprinting and electrostimulation
Warren, D., Tomaskovic‐Crook, E., Wallace, G. G., & Crook, J. M. (2021) · APL Bioengineering · doi:10.1063/5.0032196 · Cited by 28
Kim, J., Choi, H., Kang, E. K., Ji, G. Y., Kim, Y., & Choi, I. S. (2021) · Molecules · doi:10.3390/molecules26196077 · Cited by 30
Self-citationAdvances in Modeling Alzheimer's Disease In Vitro
Sharma, N. S., Karan, A., Lee, D.-H., Yan, Z., & Xie, J. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100097 · Cited by 31
Yang, Y., Seok, M., Kim, Y. E., Choi, Y., Song, J., Sulistio, Y. A., Kim, S., Chang, M., Oh, S., Nam, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01693-6 · Cited by 30
Self-citationCerebral Organoids as an Experimental Platform for Human Neurogenomics
Nowakowski, T. J., & Salama, S. R. (2022) · Cells · doi:10.3390/cells11182803 · Cited by 27
Engineering Neurovascular Unit and Blood–Brain Barrier for Ischemic Stroke Modeling
Liu, Z., Tang, Y., Zhang, Z., Liu, Q., Wang, M., Li, W., & Yang, G. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202638 · Cited by 28
Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs
Halpern, M., Brennand, K., & Gregory, J. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104562 · Cited by 30
The current landscape in Alzheimer’s disease research and drug discovery
Devenish, S. R. A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.002 · Cited by 28
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
Feldman, H., Cummings, J. L., Boxer, A. L., Staffaroni, A. M., Knopman, D. S., Rizzo, S. J. S., Territo, P. R., Arnold, S. E., Ballard, C. G., Beher, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14250 · Cited by 27
Self-citationTargeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
Fülöp, T., Tripathi, S., Rodrigues, S., Desroches, M., Bunt, T., Eiser, A. R., Bernier, F., Beauregard, P. B., Barron, A. E., Khalil, A., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s264910 · Cited by 27
Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03037-3 · Cited by 28
Chemmarappally, J. M., Pegram, H., Abeywickrama, N., Fornari, E., Hargreaves, A. J., Girolamo, L. A. D., & Stevens, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-59310-x · Cited by 29
Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models
Fernandes, S., Revanna, J. S., Pratt, J. M., Hayes, N., Marchetto, M. C., & Gage, F. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1434945 · Cited by 33
Lassen, P. S., Thygesen, C., Larsen, M. R., & Kempf, S. J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.04.003 · Cited by 26
Modeling brain development and diseases with human cerebral organoids
Shi, Y., Wu, Q., & Wang, X. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.09.006 · Cited by 28
Sullivan, M. A., Lane, S., Volkerling, A. M., Engel, M., Werry, E. L., & Kassiou, M. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28470 · Cited by 32
Liang, F., Zhang, Y., Hong, W., Dong, Y., Xie, Z., & Quan, Q. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00320 · Cited by 26
Advances in Reprogramming-Based Study of Neurologic Disorders
Nityanandam, A., & Baldwin, K. K. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0044 · Cited by 25
Park, T.-M., Kang, D., Jang, I., Yun, W., Shim, J., Jeong, Y. H., Kwak, J.-Y., Yoon, S., & Jin, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112348 · Cited by 25
Spinal cord organoids add an extra dimension to traditional motor neuron cultures
Winanto, W., Khong, Z. J., Hor, J., & Ng, S.-Y. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255966 · Cited by 25
Simpson, L. W., Szeto, G. L., Boukari, H., Good, T. A., & Leach, J. B. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.030 · Cited by 24
Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer’s disease
Ma, S., Zang, T., Liu, M.-L., & Zhang, C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00411-6 · Cited by 25
Self-citationVolloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 29
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
Boyarko, B., Podvin, S., Greenberg, B., Momper, J. D., Huang, Y., Gerwick, W. H., Bang, A. G., Quinti, L., Griciuc, A., Kim, D. Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1190402 · Cited by 24
Self-citationUbiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins
Braun, R. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00008 · Cited by 26
Preventing Alzheimer's disease by means of natural selection
Demetrius, L., & Driver, J. A. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0919 · Cited by 24
Tuning hydrogels through metal-based gelation triggers
McEwen, H. P., Du, E. Y., Mata, J. P., Thordarson, P., & Martin, A. D. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02140b · Cited by 25
Back to the origins: Human brain organoids to investigate neurodegeneration
Faravelli, I., Costamagna, G., Tamanini, S., & Corti, S. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146561 · Cited by 25
Brighi, C., Cordella, F., Chiriatti, L., Soloperto, A., & Angelantonio, S. D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00655 · Cited by 25
Yin, X., Zhou, H., Cao, T., Yang, X., Meng, F., Dai, X., Wang, Y., Li, S., Zhai, W., Yang, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08823 · Cited by 26
Metadata
- Authors
- Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., & Kim, D. Y.
- Affiliations
- Harvard University (US)
- University of Bonn (DE)
- Boston Children's Hospital (US)
- Whitehead Institute for Biomedical Research (US)
- University of California San Diego (US)
- Corresponding author
- Tanzi, Rudolph E.
- Kim, Doo Yeon
- ORCID
- Venue
- Nature
- Published
- 2014-10-12
- Volume
- 515
- Issue
- 7526
- Pages
- 274-278
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4366007
- OpenAlex
- W2126231259
- Cited by
- 1,195
- References
- 30
- Citations by year
- 2026: 67 · 2025: 75 · 2024: 95 · 2023: 88 · 2022: 112 · 2021: 111 · 2020: 141 · 2019: 109 · 2018: 109 · 2017: 87 · 2016: 97 · 2015: 87 · 2014: 14
- FWCI
- 63.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Massachusetts General Hospital
- Cure Alzheimer's Fund
- University of Edinburgh
- National Institute on Aging (5P01 AG15379, P01AG015379, R21AG031483, RF1AG048080, P50AG005134, R01AG014713, P01AG004953, P30AG062421)
- National Institute of Mental Health (R37MH060009)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK043351)
- National Institute of Neurological Disorders and Stroke (P30NS045776, R01NS045860)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, familial Alzheimer's disease, amyloid plaques, tauopathy, neurofibrillary tangles, amyloid hypothesis, presenilin 1 mutations, human neural stem cells, 3D cell culture, human neurons, beta-secretase inhibition, gamma-secretase inhibition, tau phosphorylation, drug screening model
- MeSH terms
- Alzheimer Disease, Cell Differentiation, Drug Evaluation, Preclinical, Extracellular Space, Humans, Microtubule-Associated Proteins, Models, Biological, Phosphorylation, Reproducibility of Results, Amyloid beta-Peptides, Neurites, tau Proteins, Cell Culture Techniques, Glycogen Synthase Kinase 3, Presenilin-1, Neural Stem Cells, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
